It is fever, rather than another underlying issue, that is causing defects during pregnancy.
In December, HPV screening will replace Pap smears, aligning with evidence from Australia's largest clinical trial.
Hormone therapy after menopause does not increase risk of death from cancer or heart disease, according to a new US study.
Women who commence assisted reproductive technology before age 30 have a much higher chance of success.
Most women who undergo a caesarean childbirth are prescribed more opioid (narcotic) pain medications than needed upon release from the hospital.
Positive trial results could mean earlier access to life-saving drug for mothers
A new paper is calling for a review of guidelines that restrict obese Australian women's access to assisted fertility treatment such as IVF.
Given that there are treatments available to reduce the risk once it's identified, there appears to be a clear role for routine cervical length screening as part of the regular pregnancy ultrasound examinations.
Moderate-to-late premature babies face much higher rates of developmental and behavioural delays than previously thought, an Australian-first longitudinal study by the Royal Women’s Hospital has found.
Stillbirth Foundation Australia has teamed up with the PricewaterhouseCoopers (PwC) Open Innovation Platform to encourage researchers to develop a tool to monitor foetal movements.
Details given in this document are believed to be correct at the time of printing. While proper care has been taken in the preparation, no liability for injury or damage resulting from its use. © BOC Limited 2014
The S-Monovette® is an innovative enclosed blood collection system that allows the user to draw blood from the patient using the syringe or vacuum method, uniting the advantages of both techniques in a single product.
Growing fears about incidents of violence and aggression in public hospitals and other healthcare settings was shared by more than 140 delegates of the NSW Nurses and Midwives’ Association (NSWNMA) this week.
Clinical trials will soon take place in Brisbane to test whether a drug used to treat rheumatoid arthritis could be useful in treating asthma. This comes after scientists at QIMR Berghofer Medical Research Institute found that a gene previously thought to have an anti-inflammatory effect, or no immune effect at all, is actually more likely to increase inflammation in people with asthma and allergies.